Persistent Covid-19 lasting in a patient for more than two years has led to the novel coronavirus developing dozens of new mutations in the individual, researchers discovered in a new study. The study ...

A method for making medicines against COVID-19 can be used to fight other RNA-based viruses, including Marburg, influenza, ...

Scripps professor Sumit Chanda says improving coronavirus care is especially important to get ahead of any future mutations or pandemics ...

therapy designed to target multiple SARS-CoV-2 proteins across the entire viral genome, not just the Spike protein. In Tevogen Bio’s proof-of-concept clinical trial, TVGN 489 showed efficacy in ...